Skip to main content

Table 6 hTERT mRNA level in CTCs of NPC patients and its association with clinicopathological factors

From: Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance

Factor

No.

hTERT mRNA (2-△△Ct)−(X Â± SD)

F/t value

P value

Clinical stage

 I

4

3.65 Â± 1.05

28.95

<0.01

 II

5

7.18 Â± 1.44

 III

15

10.97 Â± 2.19

 IV

9

15.13 Â± 2.92

N Stage

 N0

4

3.65 Â± 1.05

16.36

<0.01

 N1

5

7.18 Â± 1.44

 N2

17

11.86 Â± 3.26

 N3

7

14.17 Â± 2.43

T Stage

 T1

11

6.93 Â± 3.14

20.83

<0.01

 T2

6

9.25 Â± 3.03

 T3

13

12.62 Â± 1.78

 T4

3

18.85 Â± 1.30